Nuclear Medicine and Molecular Imaging Update

Full Course:  12 AMA PRA Category 1 Credits for CME / CEU / CPD(EXPIRES 8/19/25)

Course(s) are appropriate for:  Radiologists, Physicians, Subspecialist Physicians

Series 50 (NMMI50) Topics: Impact on medicine, neuroendocrine tumors, RAI resistant thyroid cancer, cardiac sarcoidosis, PET-CT’s role in lung cancer management, COVID-19 applications, PSMA PET-CT for prostate cancer, SPECT-CT, pediatric cases and much more!

Full Course:
Full Course Price:
Available in Interactive format.
Only Available Option: Full


Session 1: Impact and Future of Nuclear Medicine

0th Anniversary of the MECSNMMI and the Next 50 years and Unparalleled and Revolutionary Impact of PET Imaging on Research and Day to Day Practice of Medicine.

Session 2: Nuclear Medicine and the Neuroendocrine System

Understanding Neuroendocrine Tumors and the Role of Copper Cu 64 Dotatate; Partners in Crime: Nuclear Medicine and Surgery Defeating Endocrinopathies Through Teamwork; and RAI Resistant Thyroid Cancer: What is Next?

Session 3: Caridiac and Pumonary Applications of Nuclear Medicine and PET

Diagnosis and Treatment of Cardiac Sarcoidosis; Role of PET/CT in Management of Lung Cancr; and Lack of Association Between Atrial FTG Uptake and Atrial Fibrillation in Patients With PET/CT.

Session 4: Neuro

Machine Learning in the Imaging of Dementia and Brain FDG-PET Findings in COVID-19.

Session 5: Pediatrics, Prostate and Rheumatology

PSMA PET/CT Imaging in Prostate Cancer; Nuclear Medicine and Rheumatology; and Cases in Pediatric Nuclear Medicine.

Session 6: General Imaging Applications

Benefits of SPECT-CT and Quality and Safety in Radiology.

Course Objectives

Following this enduring material, the participants will be able to:

  • Describe FDG PET-CT’s impact on the practice of medicine.
  • Explain the value of molecular profiling in the treatment of iodine resistant thyroid cancer.
  • Discuss nuclear medicine’s involvement in the diagnostic evaluation, treatment and surveillance of cardiac sarcoidosis.
  • Describe the synergy, benefits and limitations of artificial intelligence in nuclear medicine.
  • Explain PSMA PET-CT’s enhancements to the reporting and therapy of prostate cancer.
  • Discuss the potential of whole body PET on imaging and interpretation.


Release Date: August 20, 2022
Expiration Date: August 19, 2025
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Meetings by Mail. Global is accredited by the ACCME to provide continuing medical education for physicians.
Global Education Group designates this enduring material for a maximum of 12 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All credits for this enduring material are applicable toward CME requirements for accreditation in Nuclear Medicine/PET.

Additional Information

The Mid East Chapter of the Society of Nuclear Medicine and Molecular Imaging’s historic 50th Annual Conference presents nuclear medicine’s latest trends, advances and procedures.  Adapted for the enduring material audience, Nuclear Medicine and Molecular Imaging Update features a dozen faculty members presenting this specialty’s impact on imaging, cardiology, neurology, endocrinology, oncology, rheumatology, pediatrics and much more.  Practice enhancements and professional development will be discussed, as well.  Nuclear Medicine and Molecular Imaging Update provides a well rounded refresher for all physicians and technologists involved with this area of medicine.